Table 4.
A summary of lipidic nanosystems for topical treatment of psoriasis in the past few years.
| Delivery system | Production technique | Drug | Findings |
|---|---|---|---|
| Particulate systems | |||
| SLNs | Modified emulsification and low temperature solidification method | Tacrolimus | Higher skin penetration and retention than marketed ointment (Ruihua, 2012). |
| Thin film hydration | Erlotinib + IL α 36SiRNA | Decreased epidermal hyperplasia (Boakye et al., 2017). Decreased infiltration of inflammatory cytokines. | |
| Hot ultrasonication | Methotrexate + Etanercept | Decreased transdermal permeation (Ferreira et al., 2017). | |
| Solvent injection | Mometasone Furoate | Higher skin deposition than commercial cream (Madan et al., 2014). | |
| Solvent injection | Betamethasone 17-valerate | Controlled release (Zhang and Smith, 2011). Drug retention in epidermis. |
|
| Pre-emulsion ultrasonication | Dithranol | Double drug localization than the commercial cream (Zhang and Smith, 2011). | |
| NLCs | Hot emulsion sonication | Thymol | Improved healing of psoriatic plaques in mouse models (Pivetta et al., 2018). |
| Microemulsion | Mometasone Furoate | Disappearance of parakeratosisa (Kaur, Sharma and Bedi, 2018). Increased skin deposition 2.5 times than marketed product. |
|
| High-shear homogenization | Methotrexate | Enhanced skin penetration (Pinto et al., 2014). | |
| Microemulsion technique | Clobetasol propionate | Increased drug accumulation in the stratum corneum (Silva et al., 2012). | |
| Hot homogenization | Tacrolimus | Higher penetration than commercial product (Nam et al., 2011). | |
| Thin film hydration | Calcipotriol + Methotrexate | Suppressed skin permeation of calcipotriol only (Fang, 2010). Lower skin irritation. | |
| A modified microemulsion technique | Fluticasone propionate | Improved drug encapsulation and formulation physicochemical stability (Doktorovová et al., 2010). | |
| A comparative study between SLNs and NLCs | Hot melt homogenization method | Cyclosporin & calcipotriol | Both particulate systems show deeper penetration (Arora et al., 2017). NLCs exhibited higher efficacy than SLNs and commercial gel. |
| Solvent diffusion technique | Capsaicin | Both particulate systems minimize skin irritation (Agrawal et al., 2015). NLCs show better stratum corneum permeation and retention than both SLNs and plain drug. |
|
| Microemulsification | Tretinoin | Higher efficacy and biocompatibility than the commercial product containing Tretinoin (Raza et al., 2013). Particulate lipidic systems show higher photostability and skin permeation than vesicular systems. |
|
| Lipospheres | Modified emulsion-based method | Thymoquinone | Improved histopathological and psoriatic features of psoriatic skin both in vivo and in vitro (Jain et al., 2017). Decreased TNF-α, IL-2, IL-6 and IL-1β. |
| Modified emulsion-based method | Tacrolimus + curcumin | Improved histopathological and psoriatic features of psoriatic skin in vivo (Jain et al., 2016). Decreased TNF-α, IL-17,IL-22. |
|
| Liquid crystals | Lipid melting, mixing with the aqueous phase and sonication | siRNAs | Gene downregulation GAPDH suppression (Vicentini et al., 2013). |
| siRNAs | Reduction of IL-1α and IL-6 production (Depieri et al., 2016). | ||
| Vesicular systems | |||
| Liposomes | Thin film hydration | Fusidic acid | A more stable formulation with a higher efficacy (Wadhwa et al., 2016). |
| Thin film hydration | Tretinoin | Particulate lipidic systems show higher photostability and skin permeation than vesicular systems (Raza et al., 2013). | |
| Thin film hydration | Calcipotriol | A smaller particles size (<100 nm) and a unilamellar structure which promoted skin penetration and drug deposition (Knudsen et al., 2012). | |
| Thin film hydration | Methotrexate | Increased skin permeability (Srisuk et al., 2012). | |
| Thin film hydration | Tretinoin | Higher skin deposition (Manconi et al., 2011). | |
| Niosomes | Thin film hydration | Anthocyanins | Prolonged antiinfalmmatory effect with no cytotoxicity (Manconi et al., 2011). |
| Ethosomes | Modified injection method | Psoralen | Improved permeation and skin deposition (Zhang et al., 2014). |
| The cold method | Tretinoin | Particulate lipidic systems show higher photostability and skin permeation than vesicular systems (Zhang et al., 2014). | |
| Thin film hydration | 5-aminolevulinic acid | Enhanced accumulation in both normal and hyperproliferative skin (Fang et al., 2009). Higher penetration depth Reduced TNF-α expression |
|
| A comparative study between liposomes and niosomes | Thin film hydration | Dithranol | Both vesicles showed better skin permeation both in vitro and in vivo (Agarwal et al., 2001). |
| A comparative study between emulsomes, liposomes and niosomes | Thin film hydration | Capsaicin | Emulsomes showed to be a convenient carrier achieving higher penetration and retention (R. Gupta et al., 2016). |
| SECosomesb | Solvent evaporation method | RNAi | Downregulation of the psoriatic genetic marker (human beta-defensin 2) (Desmet et al., 2016). |
| Emulsion systems | |||
| Microemulsion | Titration | Protopanaxdiol | Higher in vivo and in vitro skin deposition (Kim et al., 2018). |
| Titration | Methotrexate | Increased epidermal drug accumulation with lower systemic absorption, that is, improved efficacy and safety (Amarji et al., 2016). | |
| Aqueous phase titration | Betamethasone dipropionate + salicylic acid | Improved and sustained anti-inflammatory activity and higher skin penetration (Baboota et al., 2011). | |
| Shaking mixtures of the components of the microemulsion with the calculated ratios | Tacrolimus | Superior bioavailability (Baboota et al., 2011). | |
| Nanoemulsion | High shear homogenization | Cyclosporin | Increased drug permeability in vitro and superior skin hydration on human volunteers (Musa et al., 2017). |
| Spontaneous emulsification | Clobitasol propionate + calcipotriol | Better uptake by stratum coreum in vitro (Kaur et al., 2017). Better antipsoriatic skin activity in vivo. |
|
aA type of cell keratinization where the nuclei are retained in the stratum corneum. bA liposomal carrier developed by the authors.